Abstract
A complex set of interactions between biological, genetic, and environmental factors likely underlies the development of Alzheimer's disease (AD). Identifying which of these factors is most associated with AD is important for early diagnosis and treatment. We sought to examine genetic risk and structural brain volume on episodic memory in a sample of older adults ranging from cognitively normal to those diagnosed with AD. 686 adults (55-91 years old) completed a 3T MRI scan, baseline cognitive assessments, and biospecimen collection through the Alzheimer's Disease Neuroimaging Initiative. Hierarchical linear regression analyses examined main and interaction effects of medial temporal lobe (MTL) volume and polygenic hazard score (PHS), indicating genetic risk for AD, on a validated episodic memory composite score. Genetic risk moderated the relationship between MTL volume and memory, such that individuals with high PHS and lower hippocampal and entorhinal volume had lower memory composite scores [ΔF (1,677) = 4.057, p = 0.044, ΔR2 = 0.002]. Further analyses showed this effect was driven by the left hippocampus [ΔF(1,677) = 5.256, p = 0.022, ΔR2 = 0.003] and right entorhinal cortex [ΔF (1,677) = 6.078, p = 0.014, ΔR2 = 0.003]. Am...Continue Reading
References
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jun 1, 1991·Neuropsychology Review·R W Elwood
May 1, 1995·Neurobiology of Aging·H Braak, E Braak
Nov 1, 1993·Neurology·J C Morris
Aug 13, 1993·Science·E H CorderM A Pericak-Vance
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Oct 22, 1998·Neurology·C R JackE Kokmen
Oct 19, 2004·NeuroImage·Randy L BucknerAbraham Z Snyder
Feb 8, 2006·Archives of General Psychiatry·Margaret GatzNancy L Pedersen
Sep 22, 2006·Lancet Neurology·Basil H RidhaNick C Fox
Dec 18, 2008·Expert Review of Neurotherapeutics·Carl A Gold, Andrew E Budson
Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
Feb 10, 2011·The Journal of Neuropsychiatry and Clinical Neurosciences·Allison R KaupLisa T Eyler
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Marilyn S AlbertCreighton H Phelps
Nov 15, 2011·Current Opinion in Neurobiology·Michela Gallagher, Ming Teng Koh
Jul 12, 2012·Brain Imaging and Behavior·Paul K CraneUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Aug 22, 2012·Cold Spring Harbor Perspectives in Medicine·Richard Mayeux, Yaakov Stern
Dec 15, 2012·Lancet Neurology·Karolien BettensChristine Van Broeckhoven
Jan 22, 2013·Lancet Neurology·Clifford R JackJohn Q Trojanowski
Mar 13, 2013·Lancet Neurology·Victor L VillemagneUNKNOWN Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group
Apr 5, 2013·PLoS Genetics·Frank Dudbridge
Oct 29, 2013·Nature Genetics·J C LambertP Amouyel
Nov 19, 2013·PloS One·Perry G RidgeUNKNOWN Alzheimer’s Disease Genetics Consortium
Apr 20, 2014·Frontiers in Cellular Neuroscience·Aleksandra Maruszak, Sandrine Thuret
Nov 22, 2014·AJNR. American Journal of Neuroradiology·F D RaslauL P Mark
Feb 10, 2016·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Theresa M Harrison, Susan Y Bookheimer
Mar 23, 2017·PLoS Medicine·Rahul S DesikanAnders M Dale
Aug 22, 2017·Current Neurology and Neuroscience Reports·Neha Raghavan, Giuseppe Tosto
Nov 15, 2017·Genome Medicine·Cathryn M Lewis, Evangelos Vassos
Apr 27, 2018·Psychiatry Investigation·Seok Woo MoonYoung Chil Choi
Dec 12, 2018·Molecular and Cellular Neurosciences·Michael SchöllWilliam Jagust
Mar 14, 2019·Frontiers in Aging Neuroscience·Xiwu WangUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Apr 30, 2019·Human Brain Mapping·Long XieUNKNOWN Alzheimer's Disease Neuroimaging Initiative